Finanzwire Finanzwire
Basculer en Français
10836 Companies
235277 Keywords
164215 Articles
126032 Press releases
Headlines Articles Press releases Protenus, Inc. Remove
  1. Home
  2. Companies
  3. Protenus, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 02/07/2024 at 15:00, 2 years 6 months ago

    Protenus is Awarded Top-Performing Solutions Vendor in Two Segments for Second Consecutive Year Based on 2024 Best in KLAS Report

    Protenus, a healthcare compliance analytics platform, achieves highest score for patient privacy monitoring and drug diversion surveillance solutions for the second year in a row, as reported by 2024 Best in KLAS: Software & Services. Protenus' AI-driven solutions help healthcare organizations nationwide to proactively identify and prevent privacy data breaches and drug diversion, reducing manual tasks and focusing on better risk-reduction outcomes
    Protenus Healthcare Compliance Analytics Patient Privacy Monitoring Drug Diversion Surveillance Best In KLAS
    Logo of Protenus, Inc.
  • PRESS RELEASE

    published on 10/26/2023 at 14:00, 2 years 9 months ago

    Protenus Granted Fifth New Patent for Drug Diversion Surveillance Technology

    Logo of Protenus, Inc.
  • PRESS RELEASE

    published on 06/22/2023 at 18:00, 3 years 1 month ago

    New 2023 Diversion Digest From Protenus Spotlights the Prevalence of Drug Diversion in Healthcare

    Logo of Protenus, Inc.
  • PRESS RELEASE

    published on 03/08/2023 at 18:00, 3 years 5 months ago

    Protenus Earns Fourth Great Place to Work Certification

    Logo of Protenus, Inc.
Previous page
1 2
Accesswire
  • Published on 08/15/2026 at 00:50, 18 hours 50 minutes ago

    Revive Therapeutics Reports Grant of Options

  • Published on 08/15/2026 at 00:15, 19 hours 25 minutes ago

    Full Circle Lithium Announces Closing of Private Placement

  • Published on 08/14/2026 at 23:45, 19 hours 55 minutes ago

    AI/ML Innovations Inc. Announces Proposed Private Placement

  • Published on 08/14/2026 at 23:25, 20 hours 15 minutes ago

    NuRAN Wireless Closes $7.6 Million Financing

  • Published on 08/14/2026 at 23:00, 20 hours 40 minutes ago

    Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

View all ACCESSWIRE
EQS Group
  • Published on 08/15/2026 at 15:05, 4 hours 35 minutes ago

    Brook Gaming Officially Launches Sniper 2 Flagship Keyboard and Mouse Converter for Cross-Platform Console Gaming

  • Published on 08/15/2026 at 08:05, 11 hours 35 minutes ago

    SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15

  • Published on 08/14/2026 at 18:29, 1 day 1 hour ago

    Designated Persons Notifications

  • Published on 08/14/2026 at 18:15, 1 day 1 hour ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 08/14/2026 at 16:05, 1 day 3 hours ago

    GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON

View all EQS
Les Echos
  • Published on 08/10/2026 at 18:00, 5 days 1 hour ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 17:45, 5 days 1 hour ago

    Weekly share buyback

  • Published on 08/10/2026 at 11:53, 5 days 7 hours ago

    GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

  • Published on 08/10/2026 at 11:36, 5 days 8 hours ago

    GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026

  • Published on 08/10/2026 at 09:22, 5 days 10 hours ago

    Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy